Glioblastoma (GBM) is the most common primary brain tumor in adults an carries and
carries a terrible prognosis. The current regiment of surgical resection, radiation, and …

Diffuse midline gliomas harboring the H3 K27M mutation—including the previously named
diffuse intrinsic pontine glioma (DIPG)—are lethal high-grade pediatric brain tumors that are …

OBJECTIVE Historically, performing neurosurgery with the patient in the sitting position offered
advantages such as improved visualization and gravity-assisted retraction. However, this …

Background Immunosuppression in glioblastoma (GBM) is an obstacle to effective
immunotherapy. GBM-derived immunosuppressive monocytes are central to this. Programmed cell …

Brain tumors—particularly glioblastoma multiforme—pose an important public health problem
in the United States. Despite surgical and medical advances, the prognosis for patients …

The authors present the case of a man with a papillary craniopharyngioma, first diagnosed
at 47 years of age, who experienced multiple recurrences. Review of the pathologic …

Immunosuppression of unknown aetiology is a hallmark feature of glioblastoma and is
characterized by decreased CD4 T-cell counts and downregulation of major histocompatibility …

Background The current standard of care for glioblastoma (GBM) constitutes maximal safe
surgical resection, followed by fractionated radiation and temozolomide. This treatment …

OBJECTIVE The profound immunosuppression found in glioblastoma (GBM) patients is a
critical barrier to effective immunotherapy. Multiple mechanisms of tumor-mediated immune …

Glioblastoma (GBM) is a deadly disease without effective treatment. Because glioblastoma
stem cells (GSCs) contribute to tumor resistance and recurrence, improved treatment of GBM …